Bulk Production and Functional Analyses of Mouse CD55's Native and Deglycosylated Active Domains
Authors:
- Robert M ImmorminoRIRobert M Immormino
- Menachem ShohamMSMenachem Shoham
- M.Edward MedofMMM.Edward Medof
- 1 September 2001
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 393 (1) , 67-72
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement AttackThe Journal of Immunology, 2000
- Characterization of Mouse DAF on Transfectant Cells Using Monoclonal Antibodies Which Recognize Different EpitopesMicrobiology and Immunology, 1999
- Decay acceleration of the complement alternative pathway C3 convertaseImmunopharmacology, 1999
- Molecular cloning of murine decay accelerating factor by immunoscreeningInternational Immunology, 1996
- The molecular basis for paroxysmal nocturnal hemoglobinuriaTransfusion, 1993
- Membrane defence against complement lysis: The structure and biological properties of CD59Immunologic Research, 1993
- A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complementInternational Immunology, 1989
- The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.Journal of Experimental Medicine, 1987
- Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.Proceedings of the National Academy of Sciences, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.Journal of Experimental Medicine, 1984